• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板激动剂协同作用的特征

Characteristics of the synergistic actions of platelet agonists.

作者信息

Huang E M, Detwiler T C

出版信息

Blood. 1981 Apr;57(4):685-91.

PMID:7470619
Abstract

Platelets are activated by many different agonists that act synergistically. Since there is a characteristic pattern of responses to each agonist, and since there is a clear distinction between weak and strong agonists, understanding the nature of the synergism and its physiologic significance requires characterization of the pattern of responses to the synergistic action of the various agonists. Shape change, aggregation, and secretion of ATP by human platelets in citrated plasma were analyzed after activation by ADP, epinephrine, arachidonic acid, gamma-thrombin, or collagen, either singly or in pairs. The patterns of responses were characteristic of the agonist in higher concentration relative to its threshold concentration; if neither was clearly higher, the pattern of responses was intermediate between the responses characteristic of each agonist. No combination of weak agonists had the characteristics of a strong agonist. These results help define the extent to which platelet responses can be attributed to the synergistic actions of weak agonists.

摘要

血小板可被多种不同的激动剂协同激活。由于对每种激动剂都有特定的反应模式,而且弱激动剂和强激动剂之间有明显区别,因此要理解协同作用的本质及其生理意义,就需要对各种激动剂协同作用的反应模式进行表征。在枸橼酸盐血浆中,分别或成对地用二磷酸腺苷(ADP)、肾上腺素、花生四烯酸、γ-凝血酶或胶原激活人血小板后,分析了血小板的形态变化、聚集及ATP分泌情况。相对于阈值浓度,较高浓度激动剂的反应模式具有该激动剂的特征;如果两者浓度都没有明显更高,则反应模式介于每种激动剂的特征反应之间。弱激动剂的任何组合都不具有强激动剂的特征。这些结果有助于确定血小板反应可归因于弱激动剂协同作用的程度。

相似文献

1
Characteristics of the synergistic actions of platelet agonists.血小板激动剂协同作用的特征
Blood. 1981 Apr;57(4):685-91.
2
[Effect of heparin on platelet aggregation in vitro].[肝素对体外血小板聚集的作用]
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(6):735-49.
3
Synergism between collagen-adenosine diphosphate and collagen-epinephrine in platelets' aggregation: different dose response relationships.胶原蛋白-二磷酸腺苷与胶原蛋白-肾上腺素在血小板聚集过程中的协同作用:不同的剂量反应关系。
J Pak Med Assoc. 2009 Jun;59(6):368-71.
4
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway.血小板活化因子与其他血小板激动剂在人血小板聚集和释放中的协同作用:二磷酸腺苷及环氧化酶途径产物的作用
Thromb Res. 1985 Nov 1;40(3):359-72. doi: 10.1016/0049-3848(85)90271-3.
5
Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.对天然全血中人类血小板聚集的观察:体外聚集剂的协同作用和敏感性
Thromb Res. 1988 May 1;50(3):429-36. doi: 10.1016/0049-3848(88)90272-1.
6
Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)对人血小板中激动剂诱导的花生四烯酸释放和5-羟色胺分泌的影响。效应与激动剂类型及与PMA孵育时间的相关性。
Biochim Biophys Acta. 1987 Mar 11;927(3):429-36. doi: 10.1016/0167-4889(87)90109-1.
7
Malondialdehyde formation as an indicator of prostaglandin production by human platelets.丙二醛的形成作为人类血小板产生前列腺素的指标。
J Lab Clin Med. 1976 Jul;88(1):167-72.
8
Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.苯二氮䓬类药物抑制人血小板活化:氟西泮和地西泮抗血小板作用机制的比较。
Thromb Res. 1985 May 15;38(4):361-74. doi: 10.1016/0049-3848(85)90135-5.
9
Whole blood platelet aggregation in humans and animals: a comparative study.人类和动物的全血血小板聚集:一项比较研究。
J Surg Res. 1999 Apr;82(2):180-7. doi: 10.1006/jsre.1998.5543.
10
Effects of N-acetylglucosamine and platelet inhibitors on the synergistic interaction of platelets and aggregating agents in the presence of wheat germ agglutinin.在存在麦胚凝集素的情况下,N-乙酰葡糖胺和血小板抑制剂对血小板与聚集剂协同相互作用的影响。
Biochim Biophys Acta. 1982 Nov 24;719(2):388-95. doi: 10.1016/0304-4165(82)90114-3.

引用本文的文献

1
Dicer Neosynthesis Regulates Platelet Reactivity: A Mechanism Altered in Type 2 Diabetes.Dicer的新生合成调节血小板反应性:一种在2型糖尿病中发生改变的机制。
Circ Res. 2025 Aug 29;137(6):882-898. doi: 10.1161/CIRCRESAHA.124.325357. Epub 2025 Aug 5.
2
A Pilot Study on Probing of Imatinib Induced Platelet Dysfunction in Patients with Chronic Myeloid Leukemia-Chronic Phase and Absence of Associated Bleeding Manifestation: Trying to Solve an Enigma.一项关于慢性粒细胞白血病慢性期且无相关出血表现患者伊马替尼诱导的血小板功能障碍探究的初步研究:试图解开一个谜团。
Indian J Hematol Blood Transfus. 2021 Jan;37(1):162-166. doi: 10.1007/s12288-020-01376-8. Epub 2020 Nov 13.
3
Quality Assessment of Established and Emerging Blood Components for Transfusion.
已确立和新兴输血用血液成分的质量评估
J Blood Transfus. 2016;2016:4860284. doi: 10.1155/2016/4860284. Epub 2016 Dec 14.
4
Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation.高反应性血小板表型:与改变的 5-羟色胺转运体数量、转运动力学和对肾上腺素能共刺激的固有反应的关系。
Thromb Haemost. 2013 Jan;109(1):85-92. doi: 10.1160/TH12-03-0202. Epub 2012 Dec 6.
5
Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew.类风湿关节炎和贝赫切特病患者中吡罗昔康的血清浓度及血小板聚集抑制情况
Agents Actions. 1994 Nov;43(1-2):48-52. doi: 10.1007/BF02005764.
6
The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.在正常人体中,ADP、胶原蛋白和血清素对肾上腺素诱导的体外血小板聚集的增强作用以及萘哌地尔和多沙唑嗪对其的抑制作用。
Br J Clin Pharmacol. 1995 Apr;39(4):369-74. doi: 10.1111/j.1365-2125.1995.tb04464.x.
7
Activation of platelets by modified C-reactive protein.修饰型C反应蛋白对血小板的激活作用。
Immunology. 1982 Mar;45(3):439-47.
8
Human platelet activation by C3a and C3a des-arg.C3a和C3a去精氨酸对人血小板的激活作用
J Exp Med. 1983 Aug 1;158(2):603-15. doi: 10.1084/jem.158.2.603.
9
Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.循环儿茶酚胺的变化未能改变人血小板α-2-肾上腺素能受体的数量或对[3H]育亨宾或[3H]二氢麦角隐亭的亲和力。
J Clin Invest. 1984 Sep;74(3):1063-72. doi: 10.1172/JCI111473.
10
Specific correction of impaired acid hydrolase secretion in storage pool-deficient platelets by adenosine diphosphate.二磷酸腺苷对储存池缺陷型血小板中受损酸性水解酶分泌的特异性纠正作用。
J Clin Invest. 1988 Jun;81(6):1865-72. doi: 10.1172/JCI113532.